Your browser doesn't support javascript.
loading
Malignancies in Immunoglobulin G4-related ophthalmic disease.
Lai, Kenneth K H; Li, Emmy Y M; Chan, Regine Y C; Wong, Kenneth C W; Yu, Jimmy K S; Cheuk, W; Hui, Y H; Cheng, Andy C O; Chin, Joyce K Y; Ip, S K; Chan, W H; Kwok, Jeremy S W; Lam, W C; Io, Ida Y F; Mak, Theresa S T; Li, Kenneth K W; Lam, N M; Yip, Wilson W K; Young, Alvin L; Chan, Edwin; Ko, Callie K L; Ko, Simon T C; Yuen, Hunter K L; Tham, Clement C Y; Pang, Chi Pui; Chong, Kelvin K L.
Afiliação
  • Lai KKH; Department of Ophthalmology, 66380Tung Wah Eastern Hospital, Hong Kong.
  • Li EYM; 71113Hong Kong Eye Hospital, Hong Kong.
  • Chan RYC; Department of Ophthalmology and Visual Sciences, 13621Prince of Wales Hospital, Hong Kong.
  • Wong KCW; Department of Clinical Oncology, 13621Prince of Wales Hospital, Hong Kong.
  • Yu JKS; Department of Clinical Oncology, 13621Prince of Wales Hospital, Hong Kong.
  • Cheuk W; Department of Pathology, Queen Elizabeth Hospital, Hong Kong.
  • Hui YH; Department of Nuclear Medicine, Queen Elizabeth Hospital, Hong Kong.
  • Cheng ACO; Department of Ophthalmology, 13620Hong Kong Sanatorium & Hospital, Hong Kong.
  • Chin JKY; Department of Ophthalmology and Visual Sciences, 13621Prince of Wales Hospital, Hong Kong.
  • Ip SK; Department of Ophthalmology, 36658Tuen Mun Hospital, Hong Kong.
  • Chan WH; Department of Ophthalmology, 36658Tuen Mun Hospital, Hong Kong.
  • Kwok JSW; Department of Ophthalmology, Grantham Hospital, Hong Kong.
  • Lam WC; Department of Ophthalmology, 25809The University of Hong Kong, Hong Kong.
  • Io IYF; Department of Ophthalmology, Grantham Hospital, Hong Kong.
  • Mak TST; Department of Ophthalmology, 25809The University of Hong Kong, Hong Kong.
  • Li KKW; Department of Ophthalmology, 36611Caritas Medical Center, Hong Kong.
  • Lam NM; Department of Ophthalmology, 36621United Christian Hospital, Hong Kong.
  • Yip WWK; Department of Ophthalmology, 36621United Christian Hospital, Hong Kong.
  • Young AL; 71113Hong Kong Eye Hospital, Hong Kong.
  • Chan E; Department of Ophthalmology and Visual Sciences, 13621Prince of Wales Hospital, Hong Kong.
  • Ko CKL; Department of Ophthalmology and Visual Sciences, 13621Prince of Wales Hospital, Hong Kong.
  • Ko STC; Department of Ophthalmology, 66380Tung Wah Eastern Hospital, Hong Kong.
  • Yuen HKL; Department of Ophthalmology, 66380Tung Wah Eastern Hospital, Hong Kong.
  • Tham CCY; Department of Ophthalmology, 66380Tung Wah Eastern Hospital, Hong Kong.
  • Pang CP; 71113Hong Kong Eye Hospital, Hong Kong.
  • Chong KKL; Department of Ophthalmology and Visual Sciences, 26451The Chinese University of Hong Kong, Hong Kong.
Eur J Ophthalmol ; 33(1): 171-181, 2023 Jan.
Article em En | MEDLINE | ID: mdl-35675196
ABSTRACT

PURPOSE:

Clinical phenotypes in Immunoglobulin G4-related disease (IgG4-RD) according to the patterns of affecting organs have different risks of malignancies. We attempt to determine the association of malignancies with IgG4-related ophthalmic disease (IgG4-ROD).

DESIGN:

Retrospective cohort study.

METHODS:

Review of medical records, orbital images and histopathology reports in a territory-wide cohort of biopsy proven IgG4-ROD patients from 2005-2019.

FINDINGS:

Among 122 patients who had biopsies taken from adnexal lesions including lacrimal glands (n = 108), orbital mass (n = 30), infiltrated orbital fat (n = 10), conjunctiva (n = 2) or extraocular muscles (n = 3), 13% (16/122) developed malignancies over 73 ± 48months' follow-up. There were 9 cases of ocular adnexal lymphoma (OAL) and 7 extra-orbital malignancies. Compared with the general population, the incidence of OAL was significantly higher (standardized incidence ratios, SIRs = 10.0, 95%CI = 4.5-17.6) while that of extra-orbital malignancies was similar. The SIRs was highest within the first year (SIR = 46.7, 95%CI = 18.5-87.6) when 7 OAL were concomitantly diagnosed. Patients who developed OAL or extra-orbital malignancies were older than other patients at IgG4-ROD diagnosis (64.9 ± 7.1, 68.3 ± 8.5 versus 55.2 ± 15.0 years, P < 0.05). Asymmetric lacrimal gland enlargement (78% versus 13%), lack of frontal (0% versus 12%) or infraorbital nerve enlargement (0% versus 36%) were associated with OAL (all P < 0.05). Pre-treatment serum IgG4 level or extra-orbital IgG4-RD involvement was similar among patients with or without malignancies.

CONCLUSION:

In this biopsy-proven IgG4-ROD cohort, 7% developed OAL which was 10 times higher than the general population. Patients with asymmetric lacrimal gland enlargement or without trigeminal nerves involvement radiologically were associated with OAL.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Orbitárias / Neoplasias Orbitárias / Doença Relacionada a Imunoglobulina G4 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Orbitárias / Neoplasias Orbitárias / Doença Relacionada a Imunoglobulina G4 Idioma: En Ano de publicação: 2023 Tipo de documento: Article